Anhedonia and altered cardiac atrial natriuretic peptide following chronic stressor and endotoxin treatment in mice

Psychoneuroendocrinology

Volumn 35, Issue 2, 2010, Pages 233-240

  Wann, Boubacar Pasto ^a   Audet, Marie Claude ^a   Gibb, Julie ^a   Anisman, Hymie ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

ANP cardiac tissue; Chronic stress; Cytokines and anhedonia; Depression; Lipopolysaccharide; Plasma ANP

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC STRESS; COMORBIDITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; GENE EXPRESSION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CORTICOSTERONE; DEPRESSION; DIETARY SUCROSE; EATING; ENDOTOXINS; FOOD PREFERENCES; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; STRESS, PSYCHOLOGICAL; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73949086130     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.06.010     Document Type: Article

References (52)

1. Anisman H., Gibb J., and Hayley S. Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology (Berl.) 199 (2008) 231-244
2. Anisman H., and Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. In: Dantzer R., Wollman E.E., and Yirmiya R. (Eds). Cytokines, Stress and Depression (1999), Kluwer Academic/Plenum Publishers, New York
3. Anisman H., Merali Z., and Hayley S. Sensitization associated with stressors and cytokine treatments. Brain Behav. Immun. 17 (2003) 86-93
4. Anisman H., Merali Z., and Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog. Neurobiol. 85 (2008) 1-74
5. Anisman H., Prakash P., Merali Z., and Poulter M.O. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Behav. Brain Res. 181 (2007) 180-190
6. Ayensu W.K., Pucilowski O., Mason G.A., Overstreet D.H., Rezvani A.H., and Janowsky D.S. Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats. Physiol. Behav. 57 (1995) 165-169
7. Blunck R., Scheel O., Muller M., Brandenburg K., Seitzer U., and Seydel U. New insights into endotoxin-induced activation of macrophages: involvement of a K+ channel in transmembrane signaling. J. Immunol. 166 (2001) 1009-1015
8. Dalack G., and Roose S. Perspectives on the relationship between cardiovascular disease and affective disorder. J. Clin. Psychiatry 51 (1990) 4-11
9. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., and Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008) 46-56
10. Gibb J., Hayley S., Gandhi R., Poulter M.O., and Anisman H. Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain Behav. Immun. 22 (2008) 573-589
11. Goetze J.P., Videbaek R., Boesgaard S., Aldershvile J., Rehfeld J.F., and Carlsen J. Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease. J. Heart Lung Transplant. 23 (2004) 80-87
12. Grabie N., Hsieh D.T., Buono C., Westrich J.R., Allen J.A., Pang H., Stavrakis G., and Lichtman A.H. Neutrophils sustain pathogenic CD8+ T cell responses in the heart. Am. J. Pathol. 163 (2003) 2413-2420
13. Grippo A.J., Francis J., Beltz T.G., Felder R.B., and Johnson A.K. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol. Behav. 84 (2005) 697-706
14. Grippo A.J., Moffitt J.A., and Johnson A.K. Cardiovascular alterations and autonomic imbalance in an experimental model of depression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2002) R1333-R1341
15. Gutkowska J., Paquette A., Wang D., Lavoie J.M., and Jankowski M. Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007) R267-R275
16. Hofmann U., Heuer S., Meder K., Boehler J., Lange V., Quaschning T., Ertl G., and Bonz A. The proinflammatory cytokines TNF-alpha and IL-1 beta impair economy of contraction in human myocardium. Cytokine 39 (2007) 157-162
17. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
18. Inagaki H., Kuwahara M., and Tsubone H. Effects of psychological stress on autonomic control of heart in rats. Exp. Anim. 53 (2004) 373-378
19. Iyer V., Edelman E., and Lilly L. Pathophysiology of heart disease: a collaborative project of medical students and faculty. In: Lilly L. (Ed). Pathophysiology of Heart Disease (2006), Lippincott Williams & Wilkins 473
20. Johnson J.D., O'Connor K.A., Hansen M.K., Watkins L.R., and Maier S.F. Effects of prior stress on LPS-induced cytokine and sickness responses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003) R422-R432
21. Kim E.M., Grace M.K., Welch C.C., Billington C.J., and Levine A.S. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. Am. J. Physiol. 276 (1999) R1320-R1326
22. Lesperance F., and Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J. Psychosom. Res. 48 (2000) 379-391
23. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
24. Lumbers E.R. Angiotensin and aldosterone. Regul. Pept. 80 (1999) 91-100
25. Maes M. Evidence for an immune response in major depression: areview and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 19 (1995) 11-38
26. Mekontso-Dessap A., and Brochard L. BNP in intensive care unit: what prospect for the patient under mechanical ventilation. Réanimation 15 (2006) 48-54
27. Michener M.L., Gierse J.K., Seetharam R., Fok K.F., Olins P.O., Mai M.S., and Needleman P. Proteolytic processing of atriopeptin prohormone. Mol. Pharmacol. 30 (1986) 552-557
28. Miller G.E., Chen E., Sze J., Marin T., Arevalo J., Doll M., Ma R., and Cole S.W. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol. Psychiatry 64 (2008) 266-272
29. Mockel M., Muller R., Vollert J.O., Muller C., Carl A., Peetz D., Post F., Kohse J.K., and Lackner K.J. Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room. Clin. Chem. 51 (2005) 1624-1631
30. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 55 (1998) 580-592
31. O'Donoghue M., and Januzzi Jr. J.L. N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure. Expert Rev. Cardiovasc. Ther. 3 (2005) 487-496
32. Packer M. Current role of beta-adrenergic blockers in the management of chronic heart failure. Am. J. Med. 110 (2001) 81-94
33. Politi P., Minoretti P., Piaggi N., Brondino N., and Emanuele E. Elevated plasma N-terminal ProBNP levels in unmedicated patients with major depressive disorder. Neurosci. Lett. 417 (2007) 322-325
34. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27 (2006) 24-31
35. Redei E., Ahmadiyeh N., Baum A., Sasso D., Slone J., Solberg L., Will C., and Volenec A. Novel animal models of affective disorders. Semin. Clin. Neuropsychiatry 6 (2001) 43-67
36. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., and Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 58 (2001) 445-452
37. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol. Rev. 44 (1992) 479-602
38. Shanshan P., Yan Z., Aiyun L., and Chen P. Effect of exercise on gene expression of atrial natriuretic peptide receptor of kidney. Life Sci. 76 (2005) 1921-1928
39. Shigemi K., Morimoto T., Itoh T., Natsuyama T., Hashimoto S., and Tanaka Y. Regulation of vascular compliance and stress relaxation by the sympathetic nervous system. Jpn. J. Physiol. 41 (1991) 577-588
40. Silberman D.M., Wald M., and Genaro A.M. Effects of chronic mild stress on lymphocyte proliferative response. Participation of serum thyroid hormones and corticosterone. Int. Immunopharmacol. 2 (2002) 487-497
41. Sullivan D.R., West M., and Jeremy R. Utility of brain natriuretic peptide (BNP) measurement in cardiovascular disease. Heart Lung Circ. 14 (2005) 78-84
42. Takemura G., Takatsu Y., Doyama K., Itoh H., Saito Y., Koshiji M., Ando F., Fujiwara T., Nakao K., and Fujiwara H. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J. Am. Coll. Cardiol. 31 (1998) 754-765
43. Tannenbaum B., Tannenbaum G.S., Sudom K., and Anisman H. Neurochemical and behavioral alterations elicited by a chronic intermittent stressor regimen: implications for allostatic load. Brain Res. 953 (2002) 82-92
44. Tavener S.A., and Kubes P. Cellular and molecular mechanisms underlying LPS-associated myocyte impairment. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H800-H806
45. Tavener S.A., Long E.M., Robbins S.M., McRae K.M., Van Remmen H., and Kubes P. Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia. Circ. Res. 95 (2004) 700-707
46. Tse M.Y., Watson J.D., Sarda I.R., Flynn T.G., and Pang S.C. Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol. Cell. Biochem. 219 (2001) 99-105
47. Weber M., Mitrovic V., and Hamm C. B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide-diagnostic role in stable coronary artery disease. Exp. Clin. Cardol. 11 (2006) 99-101
48. Willner P., Towell A., Sampson D., Sophokleous S., and Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93 (1987) 358-364
49. Witthaut R., Busch C., Fraunberger P., Walli A., Seidel D., Pilz G., Stuttmann R., Speichermann N., Verner L., and Werdan K. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 29 (2003) 1696-1702
50. Worthman C.M., and Stallings J.F. Hormone measures in finger-prick blood spot samples: new field methods for reproductive endocrinology. Am. J. Phys. Anthropol. 104 (1997) 1-21
51. Wright C.E., Ebrecht M., Mitchell R., Anggiansah A., and Weinman J. The effect of psychological stress on symptom severity and perception in patients with gastro-oesophageal reflux. J. Psychosom. Res. 59 (2005) 415-424
52. Zorn-Pauly K., Pelzmann B., Lang P., Machler H., Schmidt H., Ebelt H., Werdan K., Koidl B., and Muller-Werdan U. Endotoxin impairs the human pacemaker current If. Shock 28 (2007) 655-661